GRT Capital Partners »

Galectin Therapeutics shares owned by GRT Capital Partners

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by GRT Capital Partners from 13F filings

Historical chart of GRT Capital Partners investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by GRT Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by GRT Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $23k 12k 1.92
2023-06-30 $17k 12k 1.44
2023-03-31 $25k 12k 2.10
2022-12-31 $14k 12k 1.13
2022-09-30 $20k 12k 1.67
2022-06-30 $16k 12k 1.33
2022-03-31 $19k 12k 1.58
2021-12-31 $25k 12k 2.08
2021-09-30 $47k 12k 3.92
2021-06-30 $38k 12k 3.17
2021-03-31 $26k 12k 2.17
2020-12-31 $28k 13k 2.23
2020-09-30 $32k 12k 2.67
2020-06-30 $37k 12k 3.08